MedPath

BLEPHAMIDE S.O.P.

BLEPHAMIDE S.O.P.

Discontinued
DIN Number

00307246

Drug Class

Human

Market Date

Dec 31, 1974

Company
HC

Allergan, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00307246
AIG Number0206094001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01CA02 PREDNISOLONE AND ANTIINFECTIVES
Product Specifications
Dosage FormOintment
Route of AdministrationOphthalmic
AHFS Classification52:04.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

PREDNISOLONE ACETATEActive
Strength: 0.2 %
Monograph: PREDNISOLONE ACETATE
SULFACETAMIDE SODIUMActive
Strength: 10 %
Monograph: SULFACETAMIDE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.